<?xml version="1.0" encoding="UTF-8"?>
<p id="Par123">Parents should be encouraged to continue specific therapies even during COVID-19 infections: 
 <list list-type="bullet">
  <list-item>
   <p id="Par124">Corticosteroid drugs for topical or oral use, short- or long-acting bronchodilators by inhalation spray or powder, anti-leukotriene agents, biological drugs, intramuscular adrenaline should be administered according to the individual therapeutic plan prescribed. There is no evidence that these therapies may suppress immunity or induce deterioration in case of COVID-19 infection;</p>
  </list-item>
  <list-item>
   <p id="Par125">oral antihistamines should be continued regularly to keep the skin, eyes and nasal allergy symptoms well controlled from allergens exposure;</p>
  </list-item>
  <list-item>
   <p id="Par126">for subjects not infected (or cured) by COVID-19 in subcutaneous or sublingual immunotherapy (SCIT or SLIT), the therapeutic plan must not be interrupted. SLIT is administered at home, has the advantage of avoiding contact with people infected. SCIT or SLIT must be suspended in case of a positive test or suspicion thereof immediately upon the appearance of symptoms of COVID-19 infection (or potential symptoms);</p>
  </list-item>
  <list-item>
   <p id="Par127">active and passive cigarette smoking is not recommended;</p>
  </list-item>
  <list-item>
   <p id="Par128">in the event of further deterioration, contact the doctor and/or emergency lines, such as 112. Direct access to the emergency room must be limited only for extreme urgency and seriousness [
    <xref ref-type="bibr" rid="CR81">81</xref>].
   </p>
  </list-item>
 </list>
</p>
